Improved diagnostic tool for microbiota analysis

Offentlig prosjektsammendrag

Genetic Analysis is a Norwegian biotech company with a dedicated team of scientists with expertise within molecular biology, clinical research and bioinformatics/biostatistics. The company has previously CE-marked and launched the GA-map Dysbiosis test. The test is offered as an IVD version to laboratories in Europe and as "research use only" in the US. Genetic analysis has a production unit producing reagent kits for the Dysbiosis Test as well as an in-house service laboratory facility. The majority of the scientific staff is however working in a dedicated Research and Development team that constantly improves and develops new products for analysis of the human gut microbiota. This project will build on GAs expertise in human microbiota testing. In addition to developing new and improved technological solutions for microbiota testing, GA will also aim to gain novel insight into the causal relationship between microbiota composition and clinical conditions and indications with the ultimate goal of enabling physicians to provide personalized and targeted treatment to patients.